Clinical trial
Regional Transplant Programs Study of Immunosuppressive Therapy Related Toxicities in Renal Transplant Recipients Managed at Regional or Satellite Community Nephrology Clinics
NCT00902980 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regional Transplant Programs Study of Immunosuppressive Therapy Related Toxicities in Renal Transplant Recipients Managed at Regional or Satellite Community Nephrology Clinics
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2005
- Completion date
- December 31, 2006
- Enrollment
- 264 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
kidney transplantation